List of Bioinformatics Companies in Sweden - 8
Search through the full list with powerful filtering options
Want this in Excel? Get Quote NowCompany | About |
---|---|
Acarix Malmo, Sweden | Acarix is a Swedish medical device company that innovates solutions for rapid Coronary Artery Disease (CAD) rule-out. The CE-mark approved and FDA De Novo cleared Acarix CADScor®System is for patients experiencing chest pain with suspected CAD and is designed to help reduce millions of unnecessary, invasive, costly diagnostic procedures. CADScor®System rapidly calculates a patient-specific CAD-score non-invasively with 96% confidence. Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX). |
Bionamic Lund, Skåne County, Sweden | Bionamic was founded by researchers to address the frustrating challenge of implementing digitalization in biopharma R&D. Our software platform can serve as a single source of truth for all your antibody related discovery and development data and offers an easy way to navigate it. We have put an incredible amount of thought and effort into making sure the data can be represented in a way that makes sense and helps to solve real problems. |
Moleculent Stockholm, Sweden | Moleculent is a biotechnology research company that focuses on mapping and analyzing cell-cell interactions and communication directly within their tissue environment. The company's platform allows for the detection of healthy cell function and the analysis of functional proteins, including receptors and ligands. |
Neogap Therapeutics Stockholm, Sweden | NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden. Our vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system. Our mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy. |
Phase Holographic Imaging Skiffervägen 48, 224 78 Lund | Phase Holographic Imaging is a company that specializes in live cell imaging and analysis systems, enabling label-free kinetic live cell studies during physiologically optimal conditions. They also provide time-lapse cytometers for long-term imaging and analysis of cell cultures using a patented method that allows living cells to be studied without the use of labels or dyes. |
Qlucore Lund, Sweden | Qlucore makes it easier to analyze the huge amounts of complex data that are generated by innovations in the fields of genetics and proteomics. It is done by providing powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics. The easy to use tools empowers researchers, technicians and physicians to easily interpret and explore their datasets. |
Sequrna Stockholm, Sweden | Introducing next-generation RNase inhibitors - ideal for single-cell and in situ RNA-sequencing SEQURNA's RNase inhibitor makes RNA work and sequencing pipelines more accessible, affordable, and sustainable. Unlike competitors’ recombinant RNase inhibitors, the SEQURNA inhibitor is thermostable and can be shipped and stored at room temperature without affecting performance. These features do not only simplify shipping and storage logistics, eliminate batch effects, and reduce costs for the user – but also enable new and simplified workflows as well as novel laboratory protocols including heat cycles. Propel your biotech business or research, and choose a more environmentally sustainable option for RNase inhibition in your RNA-seq workflows, by becoming an early user of SEQURNA’s RNase inhibitor. Our R&D team is keen to assist and advice in the transition. Find out more at www.sequrna.com or email us at info@sequrna.com |
Simsen Diagnostics Gothenburg, Sweden | We develop technologies for ultrasensitive analysis of complex DNA sources. Compared to other technologies for ultrasensitive sequencing, our solutions are both simple to use and specifically adapted for analysis of difficult to analyze DNA such as circulating tumor DNA, a biomarker specific for cancer. |